␤-Catenin has previously been shown to interact with presenilin 1 (PS1) in transfected cells. Here we report that ␤-catenin co-immunoprecipitates with the endogenous C-terminal fragment of presenilin 1 (PS1-CTF) but not with the endogenous CTF of presenilin 2 (PS2-CTF) in H4 human neuroglioma cells. During staurosporine (STS)-induced cell death, ␤-catenin and PS1-CTF undergo a caspase-mediated cleavage. After 12 h of STS treatment, the ␤-catenin⅐PS1-CTF interaction is abrogated. While PS1-CTF immunoprecipitated with all caspase-cleaved species of ␤-catenin, ␤-catenin holoprotein did not co-immunoprecipitate with the "alternative" caspase-derived PS1-CTF (PS1-aCTF). Thus, the abrogation of the ␤-catenin⅐PS1-CTF complex was due to caspase cleavage of PS1-CTF. ␤-Catenin co-immunoprecipitated with PS1-NTF, but only when PS1-NTF was associated with PS1-CTF. Even though PS1-NTF⅐CTF complex stability was not altered by caspase cleavage, its ability to bind ␤-catenin was abolished. Thus, while the PS1-NTF⅐CTF complex is preserved after caspase cleavage, it may no longer be fully functional.
␤-Catenin has previously been shown to interact with presenilin 1 (PS1) in transfected cells. Here we report that ␤-catenin co-immunoprecipitates with the endogenous C-terminal fragment of presenilin 1 (PS1-CTF) but not with the endogenous CTF of presenilin 2 (PS2-CTF) in H4 human neuroglioma cells. During staurosporine (STS)-induced cell death, ␤-catenin and PS1-CTF undergo a caspase-mediated cleavage. After 12 h of STS treatment, the ␤-catenin⅐PS1-CTF interaction is abrogated. While PS1-CTF immunoprecipitated with all caspase-cleaved species of ␤-catenin, ␤-catenin holoprotein did not co-immunoprecipitate with the "alternative" caspase-derived PS1-CTF (PS1-aCTF). Thus, the abrogation of the ␤-catenin⅐PS1-CTF complex was due to caspase cleavage of PS1-CTF. ␤-Catenin co-immunoprecipitated with PS1-NTF, but only when PS1-NTF was associated with PS1-CTF. Even though PS1-NTF⅐CTF complex stability was not altered by caspase cleavage, its ability to bind ␤-catenin was abolished. Thus, while the PS1-NTF⅐CTF complex is preserved after caspase cleavage, it may no longer be fully functional.
Missense mutations in presenilin 1 (PS1) 1 and presenilin 2 (PS2) are responsible for roughly 30 -40% of early onset familial Alzheimer's disease (1) . The presenilins are transmembrane proteins localized in the endoplasmic reticulum (ER) and Golgi (2) . To date, over 50 different PS1 mutations have been described, and 3 FAD mutations have been identified in PS2. Two main clusters of mutations in exon 5 and exon 8 are observed in PS1. In native cell lines and brain, full-length PS1 is not detectable as the protein constitutively undergoes endoproteolytic cleavage resulting in the production of a fragment of ϳ20 kDa (C-terminal fragment or PS1-CTF) and a fragment of ϳ30 kDa (N-terminal fragment or PS1-NTF) (3) (4) (5) . It has recently been reported that the NTF and CTF of both presenilins are associated in heterodimeric complexes in cultured cells (6, 7) and brain (8) and that ␤-catenin is also present in this complex (9) . Because FAD mutations in these proteins are associated with an increase in A␤-(1-42) both in vivo and in vitro (10 -13) , it has been suggested that PS1 and PS2 could play a role in the processing of amyloid precursor protein in the ER and/or Golgi. Another series of studies reported that PS1 and PS2 are highly homologous with Sel-12, a protein that facilitates the Notch pathway in Caenorhabditis elegans (14, 15) .
To further elucidate the biological function of presenilins, efforts have been made to identify molecules that interact with presenilins. A recent study has shown that PS1 interacts with Ѩ-catenin, a homologue of ␤-catenin. In addition, ␤-catenin has been shown to bind full-length PS1 in human embryonic kidney 293 cells overexpressing PS1 (16) .
␤-Catenin is a multifunctional protein that plays a key role in the Wingless pathway and in the regulation of cell-cell adhesion (for review see Ref. 17 ). ␤-Catenin is able to bind directly to E-cadherins and connects the adherens junctions to the actin cytoskeleton via interaction with ␣-catenin. The cytoplasmic level of ␤-catenin is highly regulated. ␤-Catenin is degraded by the proteasome following phosphorylation. In the steady state, glycogen synthase kinase 3␤ phosphorylates ␤-catenin at its N terminus. When the Wingless pathway is activated, glycogen synthase kinase 3␤ is inhibited, resulting in an increase in the cytoplasmic level of ␤-catenin and making the protein available for transportation to the nucleus where it can bind the T-cell factor/lymphoid enhancer-binding factor family of transcription factors. ␤-Catenin degradation is also activated by various negative regulators of the Wingless pathway. For example, the adenomatous polyposis coli gene product binds and down-regulates ␤-catenin.
Recently it has been shown that during apoptosis, ␤-catenin undergoes caspase-mediated cleavage (18) . The execution phase of apoptosis involves the cleavage and activation of a cascade of caspases that are responsible for the cleavage of various "cell death" substrates (for review see Ref. 19) . Caspase cleavage of ␤-catenin occurs at the N-and C-terminal regions of the protein resulting in the disruption of ␤-catenin⅐␣-catenin binding. Since ␣-catenin binds actin, caspase cleavage of ␤-catenin affects the organization of actin filaments and contributes to dismantling actin anchorage of cells during apoptosis (18) . During apoptosis, the PS1-CTF and PS2-CTF also undergo caspase-mediated "alternative" cleavage resulting in the production of smaller fragments (PS1-aCTF and PS2-aCTF) (20, 21) . The presence of FAD missense mutations in overexpressed PS2 has recently been shown to lead to increased production of PS2-aCTF (20) .
Since a previous report showed that ␤-catenin could be coimmunoprecipitated with PS1 in transfected cells, one of the aims of this study was to determine whether ␤-catenin also interacts with endogenous PS1-CTF in native human neuroglioma H4 cells. Moreover, we set out to determine whether, during apoptosis, caspase-mediated cleavage affects the interaction between PS1 and ␤-catenin and complex formation between PS1-NTF and CTF.
EXPERIMENTAL PROCEDURES
Antibodies-We used two different anti-␤-catenin monoclonal antibodies identified as anti-␤-catenin C-100 raised against the last 100 aa of the C terminus of ␤-catenin (Zymed Laboratories Inc.) and anti-␤-catenin 571-781 raised against aa 571-781 of the C terminus of ␤-catenin (Transduction Laboratories). Anti-␤-catenin 571-781 is also available as horseradish peroxidase-conjugated antibody (anti-␤-catenin HRPO, Transduction Laboratories). For immunodetection of PS1-CTF, we used 3 different antibodies: ␣PS1Loop, a polyclonal antibody raised against the large hydrophilic loop region of PS1 (gift from Dr. G. Thinakaran and Dr. S. Sisodia (3)); 4627, polyclonal antibody raised against aa 457-467 of PS1 C terminus (gift from Dr. D. Selkoe (5)), and APS 18, a monoclonal antibody raised against aa 313-334 of the loop region of PS1 (7) . For immunodetection of PS2-CTF, we used 2 different antibodies: ␣PS2Loop, a polyclonal antibody raised against the large hydrophilic loop region of PS2 (gift from Dr. G. Thinakaran and Dr. S. Sisodia (3)), and APS 26, a monoclonal antibody raised against aa 317-334 of the loop region of PS2. For immunodetection of PS1-NTF we used Ab14 antibody, a polyclonal antibody raised against 1-25 aa of PS1 (gift of Drs M. Seeger and S. Gandy (3)). A list of all antibodies used in this study is provided in Table I .
Cell Culture, Induction, and Inhibition of Cell Death-H4 human neuroglioma cells were cultured in DMEM (high glucose) containing 10% heat-inactivated fetal calf serum, 100 units/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine. For the induction of apoptosis, cells were seeded at a density of 5 ϫ 10 6 cells for each 150-mm Petri dish. After 48 h, the cell layer was washed twice with phosphatebuffered saline, and the standard medium was replaced with serumfree DMEM containing 1 M staurosporine (STS) (Calbiochem). A time course experiment was performed: H4 cells were collected at time 0, 4, 6, 8, 12, 16 , and 24 of STS treatment. Cells were pelleted by centrifugation washed once with phosphate-buffered saline. For apoptosis inhibition cells were incubated with 100 M zVAD-FMK (Enzyme System Products) and 1 M STS or STS only for 16 h in serum-free DMEM and collected as before. Cells were treated with zVAD for 1 h before STS addition. The characterization of apoptotic process in naive H4 cells in response to STS treatment including various parameters such as cell death measurement by trypan blue exclusion, caspase 3 activation, and PARP cleavage has been shown previously (20) .
Western Blot Analysis and Immunoprecipitation-Cell pellets from each time point following treatment with STS were detergent-extracted on ice using IP buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% Nonidet P-40) plus protease inhibitors. The lysates were centrifuged at 1000 ϫ g for 10 min at 4°C. The supernatants were collected, and total proteins were quantitated by the BCA protein assay kit (Pierce). For Western blot analysis, 100 g of total protein of each sample were subjected to SDS-polyacrylamide gel electrophoresis using 4 -20% gradient Tris/glycine gels under reducing conditions (Novex). Proteins were transferred to polyvinylidene difluoride membrane (BioRad) using a semi-dry electrotransfer system (Hoefer). The blots were blocked with 5% non-fat dry milk in TBST (25 mM Tris, pH 7.4, 137 mM NaCl, 0.15% Tween 20) for 1.5 h, incubated with primary antibodies (anti-␤-catenin:horseradish peroxidase-conjugated (HRPO), 1:1000 in 5% non-fat dry milk TBST; ␣PS1 Loop, 1:2500 in TBST) for 1 and 1.5 h, respectively and incubated with secondary antibodies (horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies, 1:5000 (Pierce)) in 5% non-fat dry milk TBST for 1 h. Between steps, the blots were washed with TBST for 30 min. The blots were visualized using the ECL or ECL plus Western blot detection system (Amersham). For immunoprecipitation (IP), 2 mg of total proteins for each sample were used. For quantitative co-IP experiments, increasing amounts of total protein were used (0.375 mg, 0.750 mg, 1.5 mg, 3 mg). For co-immunoprecipitation of PS1-NTF and PS1-CTF cell pellets from time point 0 and 24 of STS treatment were detergent-extracted on ice using IP buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% digitonin). The samples were precleared either with protein A (15 l) or goat antimouse-IgG magnetic bead-conjugated (45 l) (Perceptive Diagnostics) overnight in the cold room. For immunoprecipitation with monoclonal antibodies goat anti-mouse IgG magnetic bead-conjugated were precoated using 2 g of anti-␤-catenin C-100 (Zymed Laboratories Inc.), 1.5 g of anti-␤-catenin 571-781 (Transduction Laboratories), 4 g of APS18, 4 g of APS26 for each sample. After preclearing, the magnetic beads were collected using a magnetic bead collector and then discarded; the precleared lysates were collected and incubated with anti-mouse-IgG magnetic beads-conjugated precoated with the monoclonal antibodies listed above, or with 1 l of ␣PS1 Loop or ␣PS2 Loop polyclonal antibody or Ab14 antibody, and incubated overnight in the cold room. The samples immunoprecipitated with polyclonal antibodies were further incubated with Protein A magnetic beads-conjugated for 2 h in the cold room. Immunoprecipitates were washed twice in IP buffer then collected using a magnetic bead collector, heated at 50°C for 10 min in sample buffer, and subjected to SDS-polyacrylamide gel electrophoresis and Western blotting using anti-␤-catenin HRPO, 1:1000, or ␣PS1 Loop, 1:2500, ␣PS2 Loop, 1:2500, or 4627 antibody, 1:2500, Ab14 antibody, 1:2500.
RESULTS AND DISCUSSION

␤-Catenin and PS1-CTF Binding in H4 Human Neuroglioma
Cells-In this study, we set out to examine whether endogenous forms of PS1-CTF interact with ␤-catenin in H4 human neuroglioma cells and whether caspase-mediated cleavage affects this interaction. Detergent lysates prepared from H4 cells were subjected to immunoprecipitation (IP) using two different monoclonal antibodies: anti-␤-catenin C-100 and anti-␤-catenin (Fig. 1A, lanes 1 and 2, respectively) . Western blot analysis performed with anti-␤-catenin HRPO antibody detected ␤-catenin in both immunoprecipitates (Fig. 1A , upper panel, lanes 1 and 2) and in the straight lysate (lane 3). When the same blot was immunostained with ␣PS1 Loop antiserum, endogenous PS1-CTF was detected as a doublet of ϳ20 kDa and ϳ23 kDa, as previously reported in H4 cells (20) (Fig. 1A,  lower panel, lanes 1 and 2) . Thus, both ␤-catenin antibodies were able to co-IP the PS1-CTF. To confirm the binding between ␤-catenin and PS1-CTF, we carried out the reverse experiment using two different antibodies raised against different epitopes of the large hydrophilic loop of PS1: a monoclonal antibody, APS 18, and a polyclonal antiserum, ␣PS1 Loop. PS1-CTF was immunodetected in both immunoprecipitates (Fig. 1A, lower panel, lanes 4 and 5) and in the straight lysate (lane 6). The presence of ␤-catenin in PS1 immunoprecipitates was shown by immunostaining the same blot with anti-␤-catenin antibody (Fig. 1A, upper panel, lanes 4 and 5) .
To demonstrate the specificity of the interaction between ␤-catenin and PS1-CTF, we performed the same co-IP experiment using several antibodies as negative controls. Cell lysates were immunoprecipitated with two different antibodies raised against the large hydrophilic loop of PS2, ASP 26 (monoclonal) and ␣PS2 Loop (polyclonal) and with anti-␤-tubulin and antilow density lipoprotein receptor related protein (LRP) antibod- 2) , but was present in the straight lysate (Fig. 1B, upper panel, lane 3) . In negative control experiments, LRP and ␤-tubulin antibodies did not co-immunoprecipitate with ␤-catenin (data not shown). To further test the specificity of the binding between ␤-catenin and PS1-CTF, we performed a quantitative co-IP experiment (Fig. 1C) . As increasing amounts of total proteins were immunoprecipitated with anti-␤-catenin antibody, increasing amounts of ␤-catenin were detected when immunoprecipitates were subjected to Western blot analysis using anti-␤-catenin antibody (Fig. 3,  upper panel) . Developing the same blot with ␣PS1 Loop antibody, we were able to show that increasing amounts of PS1-CTF co-immunoprecipitated with correspondingly increasing amounts of ␤-catenin (Fig. 3C, lower panel) . Taken together, these data demonstrate a specific interaction between endogenous ␤-catenin and endogenous PS1-CTF in H4 cells.
Effect of Apoptosis on ␤-Catenin and PS1 Cleavage-Since it has been previously reported that both ␤-catenin (18) and the presenilins (20) are substrates for caspases, we investigated the effects of apoptosis on the processing of ␤-catenin and PS1 in our cellular model. Apoptosis was induced by treating H4 cells with staurosporine, and time course experiments were performed. When Western blot analysis of cell lysates from different time points was carried out with anti-␤-catenin C-100 antibody, ␤-catenin was not detected after 6 h of STS treatment (data not shown). We next reprobed the blot using anti-␤-catenin 571-781 antibody and detected fragments of different sizes (ϳ90 kDa, ϳ65 kDa, and intermediate species; Fig. 2, upper panel, time points 6 -24 h). Thus, during the progression of STS-induced cell death, ␤-catenin holoprotein undergoes sequential cleavage by caspases at multiple sites, resulting in the appearance of an ϳ90-kDa species at the 6-h time point, because of the removal of a frag- Upper panel, Western blot analysis of ␤-catenin using anti-␤-catenin antibody HRPO. Note that after 6 h of treatment, ␤-catenin full-length (FL) was cleaved into ϳ90-and ϳ65-kDa fragments (indicated by arrows). The ϳ65-kDa fragment becomes the predominant species during later points in the time course. Lower panel, Western blot analysis of the PS1-CTF using ␣PS1 Loop antibody. Note that the PS1-aCTF can be detected after 8 h and increases in amount during the time course coinciding with the increased appearance of the ϳ65-kDa cleavage product of ␤-catenin. ment of ϳ2 kDa from the C terminus of ␤-catenin. The 90-kDa species is then further cleaved into a smaller fragment of ϳ65 kDa that becomes the prevalent species in the latest time points (12-24 h), as described previously (26) . Thus, during apoptosis, ␤-catenin is sequentially cleaved in H4 cells in the same type of pattern that was described previously for NIH3T3 fibroblasts and Madin-Darbin canine kidney cells. When the same blot was probed with ␣PS1 Loop antibody, PS1-CTF and PS1-aCTF were immunodetected (Fig. 2, lower panel) . PS1-aCTF was only detected after 8 h of STS treatment. During the course of STSinduced cell death, the amount of PS1-aCTF increased (time points 8 -24) while PS1-CTF, which serves as a caspase substrate, was decreased in amount. While some of the light extra bands were nonspecific, the slightly higher molecular mass bands have previously been identified as phosphorylated PS1-CTF by protein kinase C (6). As expected, staurosporine, a broad spectrum protein kinase inhibitor, which was used to induce apoptosis in these cells, decreased and even eliminated these bands during the time course, as it also inhibits protein kinase C. These data show that both ␤-catenin and PS1-CTF are substrates for caspases and exhibit different temporal patterns of caspase-mediated cleavage. These data also suggest the involvement of different species of caspase, given that the PS1 caspase site does not contain the caspase 3 consensus sequence (DXXD) (in contrast to the caspase cleavage sites of ␤-catenin).
Effect of Caspase Cleavage on ␤-Catenin⅐PS1 Binding-Since both ␤-catenin and PS1 are cleaved during apoptosis, we next investigated the effects of caspase-mediated cleavage on ␤-catenin⅐PS1-CTF binding. For this purpose, we performed co-IP experiments from cell lysates corresponding to each time point of the STS time course experiments, using anti-␤-catenin 571-781 antibody (Fig. 3, A and C) , APS18, and ␣PS1 Loop (Fig. 3, B and D, respectively) . When cell lysates were immunoprecipitated with anti-␤-catenin 571-781 antibody, PS1-CTF was immunodetected by both ␣PS1 Loop (Fig. 3A, lower  panel) and by 4627 antibody (Fig. 3C, lower panel) at time points 0, 6, and 8. Neither PS1-CTF nor PS1-aCTF co-immunoprecipitated with ␤-catenin at time points 12, 16, or 24. Immunodetection of ␤-catenin in the same blot (Fig. 3, A and C,  upper panel) showed that all caspase-cleaved species were immunoprecipitated in the same temporal pattern that we previously observed in Western blot analyses (Fig. 2, upper panel) . To further confirm that ␤-catenin⅐PS1-CTF binding is abolished after 12 h of STS treatment, we performed complementary co-IP experiments using two different antibodies raised against the large hydrophilic loop of PS1 in the same set of experiments. When PS1-CTF was immunoprecipitated using APS18, all species of ␤-catenin were immunodetected at time points 0, 6, and 8 but not at 12, 16, and 24 (Fig. 3B, upper  panel) . Western blot analysis performed using ␣PS1 Loop detected only PS1-CTF in the immunoprecipitates (Fig. 3B, lower  panel) . Since APS18 did not immunoprecipitate PS1-aCTF, we used cell lysates from the same time points to immunoprecipitate with ␣PS1 Loop antibody (Fig. 3D ). ␣PS1 Loop antibody was able to pull down both PS1-CTF and PS1-aCTF as detected by the 4627 antibody (Fig. 3D, lower panel) . Again, ␤-catenin co-immunoprecipitated with the PS1-CTF, but only at time points 0, 6, and 8 (as observed when the same blot was developed with anti-␤-catenin HRPO antibody, Fig. 3D, upper  panel) .
These data show that the binding between ␤-catenin and PS1-CTF was not detected in lysates from cells treated with STS for 12 h or longer. This suggests that caspase-mediated cleavage occurs at the binding site of one or both proteins and abrogates the interaction of these proteins. Since ␤-catenin holoprotein (Fig. 3, A and B, lower panels, time 0) and all ␤-catenin caspase-cleaved species, including the ϳ65-kDa fragment of ␤-catenin, which became the predominant species in the later time points, were able to co-immunoprecipitate with PS1-CTF (Fig. 3, A and B, lower panels, time 6 and 8) and vice versa (Fig. 3, B and D, upper panels, same time points) , it is unlikely that the ␤-catenin binding site is lost at the later time points. Conversely, no binding was observed at time points 12, 16, and 24, when the amount of PS1-CTF decreased and the amount of PS1-aCTF increased. At the same time points, PS1-CTF was still detectable (Fig. 3, B and D, lower panel) but probably may have been insufficiently abundant to immunoprecipitate and detect ␤-catenin. In addition, PS1-aCTF did not co-immunoprecipitate with any of the ␤-catenin caspasecleaved species.
If the abrogation of ␤-catenin⅐PS1-CTF complex was due to the caspase-mediated cleavage of the ␤-catenin binding site of PS1-CTF and not to the caspase-mediated cleavage of ␤-catenin, ␤-catenin holoprotein, which was not present in the later time points, should have co-immunoprecipitated with PS1-CTF but not with PS1-aCTF. To test this hypothesis, we immunoprecipitated ␤-catenin in a sample containing lysates from both time point 0 and time point 24. Thus, the mixed sample contained ␤-catenin holoprotein, PS1-CTF (from time point 0 lysate, Fig. 4A, lane 1) , ␤-catenin caspase-cleaved species, and PS1-aCTF (from time point 24 lysate, Fig. 4A, lane 2) . As expected, ␤-catenin holoprotein co-immunoprecipitated with PS1-CTF at time point 0 (Fig. 4A, lane 3) and at time point 24, the prevalent ϳ65-kDa ␤-catenin fragment did not co-immunoprecipitate with either PS1-CTF or PS1-aCTF (Fig. 4A, lane 4) . In the mixed sample, ␤-catenin holoprotein co-immunoprecipitated with PS1-CTF, but not with PS1-aCTF (Fig. 4 A, lane 5) . These data show that the abrogation of the ␤-catenin⅐PS1 binding after 24 h of STS treatment (Fig. 4A, lane 4) was due to caspase-mediated cleavage of PS1-CTF.
Since it has previously been shown that PS1-NTF and PS1-CTF form an oligomeric complex (6 -8) , which also contains ␤-catenin (9), we next investigated whether ␤-catenin could be co-immunoprecipitated with PS1-NTF. PS1-NTF was not detected in immunoprecipitates from lysates extracted with 0.5% Nonidet P-40 (Fig. 4A, middle panel) . Therefore, we first determined appropriate detergent conditions for co-immunoprecipitating PS1-NTF and PS1-CTF. For this purpose, we used as a detergent 1%, 0.5%, 0.25% Nonidet P-40, 1% digitonin, or 0.25% dodecyl-D-maltoside. Immunoprecipitation was carried out using Ab14, and the reverse experiment was performed using APS18 for immunoprecipitation. The optimal detergent conditions for co-immunoprecipitating PS1-NTF with PS1-CTF and PS1-NTF with ␤-catenin was 1% digitonin (data not shown). H4 cells from time points 0 and 24 of STS treatment were incubated in lysis buffer containing 1% digitonin, and the lysates were immunoprecipitated with Ab14 (Fig. 4B, lanes 1  and 2, respectively) . Immunoprecipitates were then subjected to Western blot analysis using ␣PS1 Loop antibody (Fig. 4B,  lower panel) . PS1-NTF co-immunoprecipitated with PS1-CTF at time 0 (Fig. 4B, lower panel, lane 1) , and PS1-NTF was also able to bind both PS1-CTF and PS1-aCTF at time point 24 (Fig.  4B, lower panel, lane 2) . When the same blot was immunostained with anti-␤-catenin HRPO antibody, ␤-catenin was co-immunoprecipitated by Ab14 at time 0, but the binding was lost at time point 24, even though PS1-NTF could be successfully immunoprecipitated in both samples (Fig. 4B, middle  panel, lanes 1 and 2) . PS1-NTF co-immunoprecipitated with ␤-catenin only in detergent conditions that allowed PS1-NTF⅐PS1-CTF binding. In addition, when PS1-CTF was cleaved by caspases, not only was the binding between ␤-catenin and PS1-CTF abolished, the ␤-catenin⅐PS1-NTF binding was also lost. Moreover, binding of ␤-catenin to PS1-CTF did not require the presence of PS1-NTF. Collectively these data show that ␤-catenin binds to PS1-NTF but only via its interaction with PS1-CTF. It should also be noted that caspase-mediated cleavage of PS1-CTF did not interfere with the stability of the PS1-NTF⅐PS1-CTF complex. In fact, PS1-NTF was still able to interact with PS1-aCTF.
To test whether the disruption of the ␤-catenin⅐PS1 interaction was actually caused by caspase cleavage, we blocked caspase activation using a broad spectrum caspase inhibitor (zVAD-FMK) and performed co-IP experiments. Protein extracts from cells treated with STS in the presence or absence of zVAD for 16 h (Fig. 4C, lanes 1 and 2, respectively) were subjected to Western blot analysis and immunodetected either with anti-␤-catenin HRPO antibody (Fig. 4C, upper panel) or ␣PS1 Loop. zVAD treatment was able to completely inhibit both ␤-catenin and PS1 cleavage (Fig. 4C, lanes 1 and 2) . The same lysates were immunoprecipitated with anti-␤-catenin antibody, and immunoprecipitates were detected with ␣PS1 Loop. PS1-CTF co-immunoprecipitated with ␤-catenin in zVAD plus STS-treated cell extract (Fig. 4C, lower panel, lane 3) , but not in the cells treated with STS alone (Fig. 4C, lower panel, lane  4) , although ␤-catenin species were present in both samples as demonstrated by Western blot analysis using an anti-␤-catenin antibody (Fig. 4C, upper panel) . Thus, inhibition of caspasemediated cleavage of PS1 and ␤-catenin by zVAD treatment preserves the ␤-catenin⅐PS1-CTF interaction. Collectively, these data indicate that ␤-catenin binds the normal PS1-CTF in H4 cells, while caspase-mediated cleavage abolishes this interaction.
The initiation of the cell death program includes the proteolytic activation of caspases which, through autoactivation and activation of other caspases, results in the cleavage of a large set of cell death substrates (19) . Caspase-mediated cleavage events promote the "execution" stage of apoptosis by disrupting several types of interactions. These include DNA⅐transcription factor-DNA (e.g. SAF-A, Sp1; Refs. 22 and 23), RNA⅐RNA-binding protein (e.g. mdm2; Ref. 24) , and protein⅐protein (e.g. ␤-catenin⅐␣-catenin binding, focal adhesion kinase⅐paxillin; Refs. 18 and 25) interactions. Since ␤-catenin has been shown to play a role in the Wingless pathway and in cadherin-mediated cell-to-cell adhesion, diverse physiological functions of ␤-catenin may be mediated by different molecular interactions. It has previously been reported that caspase-mediated cleavage of ␤-catenin abrogates its interaction with ␣-catenin, thereby disrupting actin organization in the apoptotic cell (18) . Alterations in the actin cytoskeleton lead to the loss of cell-cell adhesion and changes in cell shape that are associated with anchorage-related apoptosis or anoikis (26) . We now show that the ␤-catenin⅐PS1 interaction is also abrogated by caspase activation. It is possible that the abrogation of ␤-catenin⅐PS1 binding might also contribute to the cytoskeleton alterations that lead to cellular changes that are essential for the execution of apoptosis. Moreover, since it has been shown that during apoptosis there is an increase in the production of PS1-aCTF in cells expressing FAD-linked mutant forms of PS1, 2 it is possible that in Alzheimer's patients with PS1 mutations the ␤-catenin⅐PS1-CTF interaction could be adversely affected by the increased production of PS1-aCTF, thereby leading to cellular changes that make neurons more susceptible to programmed cell death. Interestingly, in contrast, caspase cleavage did not abolish the PS1-NTF⅐CTF complex. However, following caspase cleavage, the PS1-NTF⅐CTF complex can no longer bind ␤-catenin. Thus, while the PS1-NTF⅐CTF complex is preserved after caspase cleavage, it may no longer be fully functional. Future studies will be necessary to explore how caspase-mediated effects on presenilin interactions may contribute to AD pathogenesis.
